Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1631.65
-2.75 (-0.17%)
< Home < Back

Sun Pharmaceutical Industries informs about press release

Date: 28-07-2016

Sun Pharmaceutical Industries has informed about a Press Release dated July 27, 2016 titled ‘Almirall and Sun Pharma enter into a License Agreement for Tildrakizumab in Europe for Psoriasis.’

The above information is a part of company’s filings submitted to BSE.